186 related articles for article (PubMed ID: 33455025)
1. Genetic drivers of non-cutaneous melanomas: Challenges and opportunities in a heterogeneous landscape.
Vergara IA; Wilmott JS; Long GV; Scolyer RA
Exp Dermatol; 2022 Jan; 31(1):13-30. PubMed ID: 33455025
[TBL] [Abstract][Full Text] [Related]
2. TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours.
Griewank KG; Murali R; Schilling B; Scholz S; Sucker A; Song M; Süsskind D; Grabellus F; Zimmer L; Hillen U; Steuhl KP; Schadendorf D; Westekemper H; Zeschnigk M
Br J Cancer; 2013 Jul; 109(2):497-501. PubMed ID: 23799844
[TBL] [Abstract][Full Text] [Related]
3. Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location-dependent patterns of genetic and epigenetic alterations.
Jurmeister P; Wrede N; Hoffmann I; Vollbrecht C; Heim D; Hummel M; Wolkenstein P; Koch I; Heynol V; Schmitt WD; Thieme A; Teichmann D; Sers C; von Deimling A; Thierauf JC; von Laffert M; Klauschen F; Capper D
J Pathol; 2022 Jan; 256(1):61-70. PubMed ID: 34564861
[TBL] [Abstract][Full Text] [Related]
4. Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas.
Griewank KG; Westekemper H; Murali R; Mach M; Schilling B; Wiesner T; Schimming T; Livingstone E; Sucker A; Grabellus F; Metz C; Süsskind D; Hillen U; Speicher MR; Woodman SE; Steuhl KP; Schadendorf D
Clin Cancer Res; 2013 Jun; 19(12):3143-52. PubMed ID: 23633454
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
[TBL] [Abstract][Full Text] [Related]
6. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
Larsen AC
Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
[TBL] [Abstract][Full Text] [Related]
7. Analysis of SDHD promoter mutations in various types of melanoma.
Scholz SL; Horn S; Murali R; Möller I; Sucker A; Sondermann W; Stiller M; Schilling B; Livingstone E; Zimmer L; Reis H; Metz CH; Zeschnigk M; Paschen A; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
Oncotarget; 2015 Sep; 6(28):25868-82. PubMed ID: 26327518
[TBL] [Abstract][Full Text] [Related]
8. BRAF mutations are detectable in conjunctival but not uveal melanomas.
Spendlove HE; Damato BE; Humphreys J; Barker KT; Hiscott PS; Houlston RS
Melanoma Res; 2004 Dec; 14(6):449-52. PubMed ID: 15577314
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the TP53 gene in human malignant melanomas derived from sun-exposed skin and unexposed mucosal membranes.
Ragnarsson-Olding BK; Karsberg S; Platz A; Ringborg UK
Melanoma Res; 2002 Oct; 12(5):453-63. PubMed ID: 12394187
[TBL] [Abstract][Full Text] [Related]
10. Mucosal malignant melanoma - a clinical, oncological, pathological and genetic survey.
Mikkelsen LH; Larsen AC; von Buchwald C; Drzewiecki KT; Prause JU; Heegaard S
APMIS; 2016 Jun; 124(6):475-86. PubMed ID: 27004972
[TBL] [Abstract][Full Text] [Related]
11. Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma.
Klemen ND; Wang M; Rubinstein JC; Olino K; Clune J; Ariyan S; Cha C; Weiss SA; Kluger HM; Sznol M
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32209601
[TBL] [Abstract][Full Text] [Related]
12. Anatomic site-specific patterns of gene copy number gains in skin, mucosal, and uveal melanomas detected by fluorescence in situ hybridization.
Glatz-Krieger K; Pache M; Tapia C; Fuchs A; Savic S; Glatz D; Mihatsch M; Meyer P
Virchows Arch; 2006 Sep; 449(3):328-33. PubMed ID: 16523260
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetical observations in nine ocular malignant melanomas.
Dahlenfors R; Törnqvist G; Wettrell K; Mark J
Anticancer Res; 1993; 13(5A):1415-20. PubMed ID: 8239513
[TBL] [Abstract][Full Text] [Related]
14. [Ocular melanomas : An update].
Kalirai H; Müller PL; Jaehne D; Coupland SE
Pathologe; 2017 Nov; 38(6):491-499. PubMed ID: 29038913
[TBL] [Abstract][Full Text] [Related]
15. Genetics of Ocular Melanoma: Insights into Genetics, Inheritance and Testing.
van Poppelen NM; de Bruyn DP; Bicer T; Verdijk R; Naus N; Mensink H; Paridaens D; de Klein A; Brosens E; Kiliҫ E
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396957
[TBL] [Abstract][Full Text] [Related]
16. BRAF mutations in conjunctival melanoma.
Gear H; Williams H; Kemp EG; Roberts F
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2484-8. PubMed ID: 15277467
[TBL] [Abstract][Full Text] [Related]
17. Genetic Biomarkers in Melanoma of the Ocular Region: What the Medical Oncologist Should Know.
Bol KF; Donia M; Heegaard S; Kiilgaard JF; Svane IM
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718045
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetics of iris melanomas: disparity with other uveal tract melanomas.
Sisley K; Brand C; Parsons MA; Maltby E; Rees RC; Rennie IG
Cancer Genet Cytogenet; 1998 Mar; 101(2):128-33. PubMed ID: 9494614
[TBL] [Abstract][Full Text] [Related]
19. Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomas.
Edmunds SC; Cree IA; Dí Nícolantonío F; Hungerford JL; Hurren JS; Kelsell DP
Br J Cancer; 2003 May; 88(9):1403-5. PubMed ID: 12778069
[TBL] [Abstract][Full Text] [Related]
20. Progress in the studies of etiology, epidemiology and pathogenesis of ocular melanomas.
Hu D; McCormick SA
Eye Sci; 2011 Mar; 26(1):18-22. PubMed ID: 21425491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
